How to rekindle drug discovery process through integrative therapeutic targeting?
Ashok D. B. Vaidya, Anuradha Roy, Rathnam Chaguturu · Expert Opinion on Drug Discovery · 2018
The rate of clinical failures of drug candidates during Phase I is greater than 90%, based on 9985 clinical and regulatory phase transitions recorded and analyzed from 7455 development programs, ac...